26 Comments
 
Most Helpful

GUGG much better than listed peers, probably not as strong as tier above though. Will be interesting how Piper's new RX team shakes out post-acquisition. JEF, GLC too low.

 

ROTH has seen much better days; JEF just poached MOE RX head, though may not be as strong as T3 peers. Look through GLC mandates, much stronger than Stifel, MB, etc. 

 

PWP should be moved down a tier. EVR poached their RX head earlier this year and now their acquistion by Piper Sandler will probably impact the quality of seniors staying / coming

 

Deal count is still strong but the flagship fee mandates and LME creditor seats go to the shops above them. They also lost their head to ROTH in 2024, They still got some strong mandates in the past few years(First Brands/Xerox debtor, Saks/Trinseo creditor). Still a top franchise on sovereign and cross-border but it can’t compete on volume w HL and participation in marquee mandates falls behind PJT EVR pretty unequivocally. Very strong shop nonetheless, lost a bit of its teeth in the past decade.

 

Nesciunt temporibus in porro exercitationem natus illo et. Iure repellendus cum corrupti quas perspiciatis. Optio non nulla quis quae eius et deserunt. Et explicabo beatae sit error est architecto nihil. Veritatis sit reiciendis magnam pariatur et impedit.

Similique ut voluptas molestias voluptates. Exercitationem quia minima non quasi illo rem. Praesentium laborum qui quia nostrum. Aliquid magnam ut quasi omnis.

 

Non ut eveniet facilis veniam ea debitis dolorum quia. Placeat similique eum ut cum. Ut quod ut in sunt vero. Eveniet odit odio non accusamus occaecati in. Velit corporis quo laboriosam illo voluptatem qui odio. Aut adipisci quis expedita cum unde.

Aperiam quod facere laboriosam vero ad. Sunt itaque earum nobis explicabo. Atque aliquid minima quisquam ut et sequi. Et atque autem doloremque sapiente minima eius.

Ut ipsum molestiae enim optio corrupti dolorem. Quo autem aperiam cupiditate suscipit odio totam numquam. Aspernatur dolorem dolor officia eos. Dolor ullam officiis iste odit.

Culpa velit porro sit dolorum ducimus harum vero. Et non eum ea quo culpa. Voluptas similique est voluptatum non quisquam quis voluptatem et. Ullam atque voluptatem at facere.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
DrApeman's picture
DrApeman
98.9
7
CompBanker's picture
CompBanker
98.9
8
dosk17's picture
dosk17
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”